Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report

por Johnson, Kai, Issa, Majd, Parikh, Anish, Monk, Paul, Yin, Ming, Mortazavi, Amir, Yang, Yuanquan
Publicado 2021

Salvage nivolumab and ipilimumab after prior anti‐PD‐1/PD‐L1 therapy in metastatic renal cell carcinoma: A meta‐analysis

por Yang, Yuanquan, Mori, Sherry V., Li, Mingjia, Hinkley, Megan, Parikh, Anish B., Collier, Katharine A., Miah, Abdul, Yin, Ming
Publicado 2022

The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization

por Steinberg, Amir, Van Cleave, Janet H., Parikh, Anish B., Moshier, Erin, Ru, Meng, Lawson, Molly, Marks, Douglas, Montelibano, Antoinette, Philpott, Amanda, Garner, Kourtney, Hammer, Marilyn J.
Publicado 2019

Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma

por Yang, Yuanquan, Psutka, Sarah P., Parikh, Anish B., Li, Mingjia, Collier, Katharine, Miah, Abdul, Mori, Sherry V., Hinkley, Megan, Tykodi, Scott S., Hall, Evan, Thompson, John A., Yin, Ming
Publicado 2022

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

por Qin, Qian, Jun, Tomi, Wang, Bo, Patel, Vaibhav G., Mellgard, George, Zhong, Xiaobo, Gogerly-Moragoda, Mahalya, Parikh, Anish B., Leiter, Amanda, Gallagher, Emily J., Alerasool, Parissa, Garcia, Philip, Joshi, Himanshu, MBBS, Galsky, Matthew, Oh, William K., Tsao, Che-Kai
Publicado 2022